<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is a significant source of morbidity and mortality in the United States and other Western countries </plain></SENT>
<SENT sid="1" pm="."><plain>Oral delivery of therapeutics remains the most patient accepted form of medication </plain></SENT>
<SENT sid="2" pm="."><plain>The development of an oral delivery formulation for local delivery of chemotherapeutics in the gastrointestinal tract can potentially alleviate the adverse side effects including systemic cytotoxicity, as well as focus therapy to the lesions </plain></SENT>
<SENT sid="3" pm="."><plain>Here we develop an oral formulation of the chemotherapeutic drug <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> was encapsulated in pH sensitive, mucoadhesive <z:chebi fb="0" ids="16261">chitosan</z:chebi>-coated alginate microspheres </plain></SENT>
<SENT sid="5" pm="."><plain>The microparticles were formulated to release the chemotherapeutics after passing through the acidic gastric environment thus targeting the intestinal tract </plain></SENT>
<SENT sid="6" pm="."><plain>In vivo, these particles substantially reduced the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden in an orthotopic mouse model of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and reduced mortality </plain></SENT>
</text></document>